-

Shareholder Update: Robbins LLP Reminds Investors of Class Action Lawsuit Against IronNet, Inc. (IRNT) f/k/a LGL Systems Acquisition Corp.

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP reminds investors of a class action on behalf of all persons and entities that purchased or otherwise acquired IronNet, Inc. (NYSE: IRNT) f/k/a LGL Systems Acquisition Corp. securities between September 15, 2021 and December 15, 2021, for violations of the Securities Exchange Act of 1934. IronNet designs and develops solutions for the prevention of cyber attacks.

If you would like more information about IronNet Inc.'s misconduct, click here.

What is this Case About: IronNet, Inc. (IRNT) Misrepresented its Business and Financial Prospects by Failing to Predict Timing of Significant Customer Opportunities

According to the complaint, on August 27, 2021, IronNet became a publicly traded company via merger with LGL Systems Acquisition Corp. IronNet's financial projections, which shareholders relied upon in voting for the merger, forecasted fiscal year 2022 revenues of $43 million to $45 million and annual recurring revenue ("ARR") of $75 million.

On September 14, 2021, IronNet announced disappointing second quarter 2022 financial results of $6.1 million for Q2 2022 compared to $7.9 million for Q2 2021 and a net loss of $17.2 million. Notwithstanding, IronNet affirmed its projections and assured investors it was "on target with our first half guidance." The result was a 38% increase in the stock price and a closing stock price of $32.13 per share.

However, by December 15, 2021, the Company slashed its expected fiscal year 2022 revenue to just $26 million with ARR of approximately $30 million. The Company also announced it had terminated its Chief Revenue Officer. On this news, IronNet's stock fell 31% to close at $4.66 per share on December 15, 2021.

During the class period, IronNet materially overstated its business and financial prospects. Specifically, the Company was unable to predict the timing of significant customer opportunities, which constituted a substantial portion of its publicly-issued FY 2022 financial guidance.

Next Steps: If you acquired shares of IronNet, Inc. (IRNT) between September 15, 2021 and December 15, 2021, you have until June 21, 2022, to ask the court to appoint you lead plaintiff for the class. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against IronNet, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:IRNT

Release Summary
IronNet, Inc. (IRNT) Misrepresented its Business and Financial Prospects by Failing to Predict Timing of Significant Customer Opportunities
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Robbins LLP Informs Investors of the Securities Class Action Against Oracle Corporation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware. For more information,...

Investor Notice: Robbins LLP Informs Investors of the Smart Digital Group Limited Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Smart Digital Group Limited (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025. Smart Digital, together with its subsidiaries, provides internet media, business planning and consulting, event planning and execution, and software customization and marketing services in Mainland China and Macau. For more information, submit a fo...
Back to Newsroom